Clinical Trial Update: Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cisplatin/etoposide with radiotherapy, with optional consolidation docetaxel, in advanced stage III non-small cell lung cancer has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Etoposide (Etoposide)

Snippet

Sponsor: Nasser Hanna, M.D. | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-02-08